Form 4: Haemonetics Corp Director Zane Acquires Restricted Stock Units

Director Ellen M. Zane acquired 2,207 restricted stock units of Haemonetics Corp on July 25, 2024.

Summary

• On July 25, 2024, Ellen M. Zane, a director of Haemonetics Corp, acquired 2,207 restricted stock units (RSUs).
• These RSUs were issued under the company's Amended and Restated 2019 Long-Term Incentive Compensation Plan.
• The RSUs vest 100% on the first anniversary of the grant date.
• Each RSU represents the right to receive one share of Haemonetics Corp's common stock upon vesting.
• Following the transaction, Ms. Zane beneficially owns 16,680 shares of Haemonetics Corp.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of RSUs is a standard practice and indicates confidence in the company's future. There are no explicitly negative aspects mentioned.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.
• The vesting schedule aligns the director's interests with the long-term success of the company.

Future Outlook

The document does not contain any specific forward-looking statements, but the vesting of the RSUs on the first anniversary of the grant date suggests a one-year horizon for aligning the director's interests with the company's performance.

Industry Context

This type of equity compensation is common in publicly traded companies to incentivize and align the interests of directors and management with shareholders.

Comparison to Industry Standards

• Equity compensation for board members is a standard practice across publicly traded companies.
• Companies like Medtronic, Boston Scientific, and Abbott also use RSUs and stock options to align director and executive compensation with shareholder value.
• The vesting schedule of one year is fairly standard, although some companies may use longer vesting periods to encourage longer-term commitment.

Stakeholder Impact

• Shareholders: Aligns director's interests with shareholder value through equity compensation.
• Employees: Reinforces the company's commitment to incentivizing key personnel.
• Management: Supports the overall compensation strategy for leadership.

Key Dates